Cambridge Healthtech Institute’s 16th Annual
Engineering Bispecific and Multifunctional Antibodies
Achieving Unprecedented Efficacy
May 15-16, 2025
Substantial progress has been made in the effort to engineer multifunctional and multispecific antibodies using novel platforms, improved manufacturing, and novel functionalities. The original forum on this topic, the 16th Annual Engineering Bispecific and Multifunctional Antibodies: Achieving Unprecedented Efficacy conference at the PEGS Boston Summit brings together industry and research leaders to showcase the advancement of engineering strategies and approaches for the creation of unique and efficacious bi- and multispecific antibody constructs.
Coverage will include, but is not limited to:
- Reviewing armored bispecifics and conditional activation strategies
- Engineering degraders and proTACs
- Designing bispecifics against solid tumors
- Creating immune engagers with improved therapeutic indices
- Integrating ML/AI in the selection and optimization of bispecific antibodies
- Selecting targets for bispecific ADCs
- Predicting developability of bispecific molecules with ML/AI tools
- Investigating novel mechanisms of action
The deadline for priority consideration is October 11, 2024.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: